Logo 1 Logo 2

Clinical Trial Details

Trial ID: L5145
Source ID: NCT00854503
Associated Drug: Simvastatin
Title: Metabolic and Vascular Effects of Statins in Untreated Dyslipidemic Diabetic Patients
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Type 2 Diabetes|Diabetic Dyslipidemia
Interventions: DRUG: Simvastatin|DRUG: Rosuvastatin
Outcome Measures: Primary: Glucose tolerance assessed by HbA1c and fasting glucose, 1, 6, 12 months | Secondary: insulin-resistance assessed by clamp. Endothelial function assessed by FMD %. Inflammatory status assessed by biochemical markers., 1, 6, 12 months.
Sponsor/Collaborators: Sponsor: University of Rome Tor Vergata
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 30
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Start Date: 2008-09
Completion Date: 2010-12
Results First Posted:
Last Update Posted: 2011-05-12
Locations: University of Rome Tor Vergata, Rome, 00133, Italy
URL: https://clinicaltrials.gov/show/NCT00854503